Cargando…
Comparison of glucocorticoids and painkiller prescribed days between rheumatoid arthritis patients receiving early and late treatment with a biological agent via a population-based cohort study
Comparison between early biologics treatment and late biologics treatment of rheumatoid arthritis (RA) patients in decreasing prescription days of glucocorticoids and painkillers by using the Taiwan National Health Insurance Research database from January 1, 1997 to December 31, 2013. We defined ear...
Autores principales: | Lee, Zon-Min, Yang, Yao-Hsu, Kuo, Ho-Chang, Shen, Ya-Han, Yu, Hong-Ren, Su, Yu-Jih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704960/ https://www.ncbi.nlm.nih.gov/pubmed/36451493 http://dx.doi.org/10.1097/MD.0000000000031986 |
Ejemplares similares
-
Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate
por: Migita, Kiyoshi, et al.
Publicado: (2015) -
A case of chronic eosinophilic pneumonia associated with rheumatoid arthritis in glucocorticoid-free remission with JAK inhibitor: A case report
por: Yamane, Takashi, et al.
Publicado: (2023) -
Herpes Zoster in rheumatoid arthritis patients receiving tofacitinib, a single center experience from Taiwan
por: Chen, Yen-Ju, et al.
Publicado: (2020) -
Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis
por: Yu, Kuang-Hui, et al.
Publicado: (2022) -
Efficacy and safety of low-dose glucocorticoids combined with methotrexate and hydroxychloroquine in the treatment of early rheumatoid arthritis: A single-center, randomized, double-blind clinical trial
por: Hua, Li, et al.
Publicado: (2020)